1. Home
  2. ELVA vs NBP Comparison

ELVA vs NBP Comparison

Compare ELVA & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

HOLD

Current Price

$8.99

Market Cap

359.5M

Sector

N/A

ML Signal

HOLD

NBP

NovaBridge Biosciences American Depositary Shares

N/A

Current Price

$2.32

Market Cap

379.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELVA
NBP
Founded
1996
2014
Country
Canada
United States
Employees
N/A
32
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
359.5M
379.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ELVA
NBP
Price
$8.99
$2.32
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$9.00
AVG Volume (30 Days)
350.7K
755.7K
Earning Date
05-13-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$34.68
N/A
Revenue Next Year
$51.48
N/A
P/E Ratio
$78.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$2.10
52 Week High
$11.88
$5.19

Technical Indicators

Market Signals
Indicator
ELVA
NBP
Relative Strength Index (RSI) 50.84 36.47
Support Level $7.10 $2.27
Resistance Level $11.67 $2.78
Average True Range (ATR) 0.62 0.14
MACD -0.04 0.01
Stochastic Oscillator 40.43 9.47

Price Performance

Historical Comparison
ELVA
NBP

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.

Share on Social Networks: